FXR agonist 9
FXR agonist 9 (compound 26) is an oral active and selectivity FXR partial agonist with the EC50 of 0.09 µM (75.13 % maximum efficacy). FXR agonist 9 ameliorates pathological features in HFD and CCl4 -induced metabolic dysfunction-associated steatohepatitis mice[1].
Product Specifications
CAS Number
2982502-32-7
UNSPSC
12352211
Target
FXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/fxr-agonist-9.html
Smiles
O=C(NC1=CC=CC=C1C(NC2=CC=CC(C(O)=O)=C2)=O)CCCOC3=CC=C(C(C)(C)C)C=C3
Molecular Formula
C28H30N2O5
Molecular Weight
474.55
References & Citations
[1]Chen C, et al. Design, synthesis and FXR partial agonistic activity of anthranilic acid derivatives bearing aryloxy moiety as therapeutic agents for metabolic dysfunction-associated steatohepatitis. Bioorg Chem. Published online November 3, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041060-100 1x 100 µL
Chromogranin A (CGA414 + CGA/777 + CGA/798), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
